Evidence map›Paper›PMID 34510322›Full record

ReviewMolecular biology reports2021

The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis.

Ghader Babaei, Negin Raei, Attabak Toofani Milani, Shiva Gholizadeh-Ghaleh Aziz, Nima Pourjabbar, Faezeh Geravand

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. microRNAs as Biomarkers of Breast Cancer.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Biomedicines · 2022
    Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Ghader BabaeiDepartment of Clinical Biochemistry, Faculty of Medicine, Urmia Medical Sciences University (UMSU), Urmia, Iran.
Negin RaeiDigestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Attabak Toofani MilaniDepartment of Biochemistry, Faculty of Medicine, Tabriz Branch, Islamic Azad University, Ahar Three Way, First Basmenj Road, Tabriz, Iran. toofani2020@yahoo.com.ORCID http://orcid.org/0000-0003-2081-3984
Shiva Gholizadeh-Ghaleh AzizDepartment of Clinical Biochemistry, Faculty of Medicine, Urmia Medical Sciences University (UMSU), Urmia, Iran. gholizadeh.sh@umsu.ac.ir.ORCID http://orcid.org/0000-0003-1949-4381
Nima PourjabbarDepartment of Medical Sciences, Faculty of Paramedical Branch, Islamic Azad University, Urmia, Western Azarbaijan, Iran.
Faezeh GeravandDepartment of Nutrition, Bushehr University of Medical Sciences, Bushehr, Iran.
Urmia University · IRArdabil University of Medical Sciences · IRBushehr University of Medical Sciences · IRIslamic Azad University of Tabriz · IRIslamic Azad University of Urmia · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCancer is the second major threat to human society and one of the main challenges facing healthcare systems. One of the main problems of cancer care is the metastases of cancer cells that cause 90% of deaths due to cancer. Multiple molecular mechanisms are involved in cancer cell metastasis. Therefore, a better understanding of these molecular mechanisms is necessary for designing restrictive strategies against cancer cell metastasis. Accumulating data suggests that MicroRNAs (miRNAs) are involved in metastasis and invasion of human tumors through regulating multiple genes expression levels that are involved in molecular mechanisms of metastasis. The goal of this review is to present the molecular pathways by which the miR 200 family manifests its effects on EMT, cancer stem cells, angiogenesis, anoikis, and the effects of tumor cell metastases.

methodsA detailed literature search was conducted to find information about the role of the miR-200 family in the processes involved in metastasis in various databases.

resultsNumerous lines of evidence revealed an association between the mir-200 family and metastasis of human tumors by impressing processes such as cancer stem cells, EMT, angiogenesis, and anoikis.

conclusionsUnderstanding the molecular mechanisms associated with metastasis in which the miR-200 family is involved can be effective in treating metastatic cancers.

Indexed as

AnimalsAnoikisAntineoplastic AgentsEpithelial-Mesenchymal TransitionHumansMicroRNAsNeoplasm MetastasisNeoplastic Stem CellsNeovascularization, PathologicAntineoplastic AgentsMicroRNAsAngiogenesisAnoikisCancer stem cellsEMTMetastasis

Identifiers

PMID34510322
OpenAlexW3200411816

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.